Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1500
0.00 (0.00%)
Aug 21, 2026, 4:10 PM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 77 million as of August 21, 2026. Its market cap has decreased by -14.45% in one year.
Market Cap
77.00M
Enterprise Value
49.48M
Revenue
4.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
ChartMarket Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 77.00M, an increase of 123.21%. That is a compound annual growth rate of 6.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 77.00M | 0.05% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 115.30M |
| Alterity Therapeutics | 109.84M |
| Paradigm Biopharmaceuticals | 100.98M |
| LTR Pharma | 90.89M |
| Prescient Therapeutics | 84.12M |
| Arovella Therapeutics | 77.36M |
| Immutep | 75.16M |
| Avecho Biotechnology | 73.41M |